NCT00419965View on ClinicalTrials.gov

Measuring G Protein-coupled Receptor Kinase-2 (GRK2) in the Blood to Diagnose and Treat Patients With Heart Failure

CompletedOBSERVATIONAL

Enrollment

582

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions

Heart Failure

Trial Locations (1)

19107

Thomas Jefferson University, Philadelphia

Sponsors

Collaborators (1)

Johnson & Johnson

All Listed Sponsors

collaborator

Johnson & Johnson

INDUSTRY

lead

Thomas Jefferson University

OTHER

NCT00419965 - Measuring G Protein-coupled Receptor Kinase-2 (GRK2) in the Blood to Diagnose and Treat Patients With Heart Failure | Biotech Hunter | Biotech Hunter